These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30174283)

  • 1. Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig.
    Xu Z; Wise MC; Choi H; Perales-Puchalt A; Patel A; Tello-Ruiz E; Chu JD; Muthumani K; Weiner DB
    EBioMedicine; 2018 Sep; 35():97-105. PubMed ID: 30174283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eCD4-Ig Variants That More Potently Neutralize HIV-1.
    Fetzer I; Gardner MR; Davis-Gardner ME; Prasad NR; Alfant B; Weber JA; Farzan M
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
    Davis-Gardner ME; Gardner MR; Alfant B; Farzan M
    PLoS Pathog; 2017 Dec; 13(12):e1006786. PubMed ID: 29253851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin.
    Vamva E; Ozog S; Leaman DP; Yu-Hong Cheng R; Irons NJ; Ott A; Stoffers C; Khan I; Goebrecht GKE; Gardner MR; Farzan M; Rawlings DJ; Zwick MB; James RG; Torbett BE
    Mol Ther Methods Clin Dev; 2023 Mar; 28():366-384. PubMed ID: 36879849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
    Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modeling of impact of eCD4-Ig molecule in control and management of HIV within a host.
    Lee TJ; Vazquez JA; Rao ASRS
    Math Biosci Eng; 2021 Aug; 18(5):6887-6906. PubMed ID: 34517562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.
    Muthumani K; Flingai S; Wise M; Tingey C; Ugen KE; Weiner DB
    Hum Vaccin Immunother; 2013 Oct; 9(10):2253-62. PubMed ID: 24045230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics.
    Gardner MR
    Front Cell Infect Microbiol; 2020; 10():176. PubMed ID: 32391289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo.
    Yu Y; Fu L; Jiang X; Guan S; Kuai Z; Kong W; Shi Y; Shan Y
    Mol Immunol; 2016 Dec; 80():68-77. PubMed ID: 27835755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.
    Verkoczy L; Alt FW; Tian M
    Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo.
    Muthumani K; Wise MC; Broderick KE; Hutnick N; Goodman J; Flingai S; Yan J; Bian CB; Mendoza J; Tingey C; Wilson C; Wojtak K; Sardesai NY; Weiner DB
    PLoS One; 2013; 8(12):e84234. PubMed ID: 24391921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
    Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
    J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
    Rosenberg Y; Sack M; Montefiori D; Labranche C; Lewis M; Urban L; Mao L; Fischer R; Jiang X
    PLoS One; 2015; 10(3):e0120451. PubMed ID: 25807114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity.
    Wise MC; Xu Z; Tello-Ruiz E; Beck C; Trautz A; Patel A; Elliott ST; Chokkalingam N; Kim S; Kerkau MG; Muthumani K; Jiang J; Fisher PD; Ramos SJ; Smith TR; Mendoza J; Broderick KE; Montefiori DC; Ferrari G; Kulp DW; Humeau LM; Weiner DB
    J Clin Invest; 2020 Feb; 130(2):827-837. PubMed ID: 31697648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.
    Brady JM; Baltimore D; Balazs AB
    Immunol Rev; 2017 Jan; 275(1):324-333. PubMed ID: 28133808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.
    Wang Q; Jiang W; Chen Y; Liu P; Sheng C; Chen S; Zhang H; Pan C; Gao S; Huang W
    J Virol; 2014 Feb; 88(4):1924-34. PubMed ID: 24284319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function.
    Richardson SI; Ayres F; Manamela NP; Oosthuysen B; Makhado Z; Lambson BE; Morris L; Moore PL
    Front Immunol; 2021; 12():733958. PubMed ID: 34566999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.
    Khawaja G; Buronfosse T; Jamard C; Guerret S; Zoulim F; Luxembourg A; Hannaman D; Evans C; Hartmann D; Cova L
    Virology; 2012 Mar; 425(1):61-9. PubMed ID: 22284894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.